Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash from Operations (2019 - 2025)

Outset Medical (OM) has disclosed Cash from Operations for 7 consecutive years, with 9521000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 42.25% to 9521000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 46327000.0 through Dec 2025, up 60.17% year-over-year, with the annual reading at 46327000.0 for FY2025, 60.17% up from the prior year.
  • Cash from Operations for Q4 2025 was 9521000.0 at Outset Medical, down from 6320000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 4823000.0 in Q2 2025, with the low at 45912000.0 in Q1 2024.
  • Average Cash from Operations over 5 years is 28499800.0, with a median of 31758500.0 recorded in 2021.
  • The sharpest move saw Cash from Operations plummeted 60.92% in 2021, then surged 85.53% in 2025.
  • Over 5 years, Cash from Operations stood at 32676000.0 in 2021, then decreased by 5.6% to 34507000.0 in 2022, then increased by 29.17% to 24442000.0 in 2023, then soared by 32.54% to 16488000.0 in 2024, then surged by 42.25% to 9521000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 9521000.0, 6320000.0, and 4823000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.